参考文献/References:
[1] 程晋.DNA损伤修复及细胞周期检控点激活的研究进展.国际放射医学核医学杂志,2009, 33(6):360-364.
[2] 张占春.电离辐射损伤与DNA修复基因.国际放射医学核医学杂志,2004,28(1):26-29.
[3] 杨青山,樊飞跃.Ku蛋白与DNA修复.国际放射医学核医学杂志,2008, 32(1):40-43.
[4] 任振义,金一尊.Ku蛋白在肿瘤发生中的作用及其靶向抑制策略.国际放射医学核医学杂志,2008, 32(5):305-307.
[5] 王芹.X射线修复交叉互补基因功能的研究进展,国际放射医学核医学杂志,2005,29(3):132-136.
[6] Jorgensen TJ, Helzlsouer KJ, Clipp SC, et al. DNA repair gene variants associated with benign breast disease in high cancer risk women. Cancer Epidemiol Biomarkers Prev, 2009,18(1):346-350.
[7] Loizidou MA, Michael T, Neuhausen SL, et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat, 2008, 112(3):575-579.
[8] Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 2006,27(3):560-567.
[9] Yen CY, Liu SY, Chen CH, et al. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med, 2008,37(5):271-277.
[10] Moreno V, Gemignani F, Landi S, et al. Polymorphisms in genes of nucleotide and base excision repair:risk and prognosis of colorectal cancer. Clin Cancer Res, 2006, 12(7 Pt 1):2101-2108.
[11] Matullo G, Guarrera S, Sacerdote C, et al. Polymorphisms/haplo-types in DNA repair genes and smoking:a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev, 2005, 14(11 Pt 1):2569-2578.
[12] Romanowicz-Makowska H, Smolarz B, Zadrozny M, et al. The association between polymorphisms of the RAD51-G135C, XRCC2-Argl88His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol, 2012, 33(2):145-150.
[13] Lin WY, Camp NJ, Cannon-Albright LA, et al. A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet, 2011,48(7):477-484.
[14] Yu KD, Chen AX, Qiu LX, et al. XRCC2 Argl88His polymorphism is not directly associated with breast cancer risk:evidence from 37, 369 subjects. Breast Cancer Res Treat, 2010, 123(1):219-225.
[15] Pooley KA, Baynes C, Driver KE, et al. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2008, 17(12):3482-3489.
[16] Curtin K, Lin WY, George R, et al. Genetic variants in XRCC2:new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 2009, 18(9):2476-2484.
[17] Krupa R, Sliwinski T, Wisniewska-Jarosinska M, et al. Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer-a case control study. Mol Biol Rep, 2011, 38(4):2849-2854.
[18] Jiao L, Hassan MM, Bondy ML, et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol, 2008,103(2):360-367.
[19] Li D, Liu H, Jiao L, et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res, 2006, 66(6):3323-3330.
[20] Wang R, Wang W, Zhang JW. Correlation between XRCC2 and XRCC5 single nucleotide polymorphisms and drug-sensitivity of human lung cancer cells. Zhonghua Yi Xue Za Zhi, 2008, 88(43):3059-3062.
[21] Bastos HN, Antao MR, Silva SN, et al. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid, 2009,19(10):1067-1075.
[22] Webb PM, Hopper JL, Newman B, et al. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev, 2005,14(2):319-323.
[23] Jakubowska A, Gronwald J, Menkiszak J, et al. The RAD51135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev, 2007, 16(2):270-275.
[24] Wisniewska-Jarosiftska M, SliwiAfski T, Krupa R, et al. The role of Rad51 gene polymorphism in patients with colorectal cancer in the Polish subpopulation. Pol Merkur Lekarski, 2009, 26(155):455-457.
相似文献/References:
[1]李平,宗天舟,季晓芹,等.CD133+U87人脑胶质瘤干细胞放射敏感性和DNA双链断裂损伤修复的实验研究[J].国际放射医学核医学杂志,2013,37(3):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
LI Ping,ZONG Tian-zhou,JI Xiao-qin,et al.CD133 positive U87 glioma stem cell radiosensitivity and DNA double-strand break repair[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
[2]谭伟,让蔚清,周平坤.癌干细胞与肿瘤的放射抗性[J].国际放射医学核医学杂志,2013,37(3):177.[doi:10.3760/cma.j.issn.1673-4114.2013.03.012]
TAN Wei,RANG Wei-qing,ZHOU Ping-kun.Cancer stem cell and its relevance to tumors resistance to radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):177.[doi:10.3760/cma.j.issn.1673-4114.2013.03.012]
[3]杜利清,刘强,王彦,等.Ku70对同源重组修复蛋白Rad51的调节作用[J].国际放射医学核医学杂志,2013,37(5):272.[doi:10.3760/cma.j.issn.1673-4114.2013.05.005]
DU Li-qing,LIU Qiang,WANG Yan,et al.Regulation of homologous recombination repair protein Rad51 by Ku70[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):272.[doi:10.3760/cma.j.issn.1673-4114.2013.05.005]
[4]王芹,刘晓秋,刘强,等.DNA双链断裂修复途径中重要的修复蛋白[J].国际放射医学核医学杂志,2013,37(1):34.[doi:10.3760/cma.j.issn.1673-4114.2013.01.010]
WANG Qin,LIU Xiao-qiu,LIU Qiang,et al.Important DNA repair proteins in DNA double-strand break repair pathways[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):34.[doi:10.3760/cma.j.issn.1673-4114.2013.01.010]
[5]王宏,刘强,杜丽清,等.DNA修复基因hOGG1的寡核苷酸多态性与癌症遗传易感性的关系[J].国际放射医学核医学杂志,2012,36(2):101.[doi:10.3760/cma.j.issn.1673-4114.2012.02.011]
WANG Hong,LIU Qiang,DU Li-qing,et al.Single nucleotide polymorphism of DNA repair gene hOGG1 and genetic susceptibility of cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):101.[doi:10.3760/cma.j.issn.1673-4114.2012.02.011]
[6]陈晓毓,李希圣,林夏鸿,等.肥胖患者脂联素基因第45位点单核苷酸多态性与血浆脂联素水平及胰岛素抵抗的相关性研究[J].国际放射医学核医学杂志,2012,36(5):269.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.003]
CHEN Xiao-yu,LI Xi-sheng,LIN Xia-hong,et al.Association of single nucleotide polymorphism at position 45 in adiponectin gene with plasma adiponectin level and insulin resistance in obesity[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):269.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.003]
[7]郭阳.错配修复系统缺陷对肿瘤放化疗的影响[J].国际放射医学核医学杂志,2011,35(6):363.[doi:10.3760,cma.j.issn.1673-4114.2011.06.011]
GUO Yang.The effect of mismatch repair deficiency on chemotherapy and radiotherapy in tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):363.[doi:10.3760,cma.j.issn.1673-4114.2011.06.011]
[8]程晋,邹仲敏.DNA损伤修复及细胞周期检控点激活的研究进展[J].国际放射医学核医学杂志,2009,33(6):360.[doi:10.3760/cma.j.issn.1673-4114.2009.06.014]
CHENG Jin,ZOU Zhong-min.The activation of DNA damage repair and cell cycle checking point[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):360.[doi:10.3760/cma.j.issn.1673-4114.2009.06.014]
[9]任振义,金一尊.Ku蛋白在肿瘤发生中的作用及其靶向抑制策略[J].国际放射医学核医学杂志,2008,32(5):305.
REN Zhen-yi,JIN Yi-zun.The role of Ku protein in the development of carcinogenesis and potential strategy for silencing it[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):305.
[10]杨青山,樊飞跃.Ku蛋白与DNA修复[J].国际放射医学核医学杂志,2008,32(1):40.
YANG Qing-shan,FAN Fei-yue.Ku protein and DNA repair[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):40.